DIFFUSION PHARMACEUTICALS IN - COM NEW (DFFN)

CUSIP: 253748206

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM NEW
Total 13F shares
3,858,704
Share change
+19,068
Total reported value
$1,765,000
Price per share
$0.46
Number of holders
13
Value change
+$5,856
Number of buys
5
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 253748206?
CUSIP 253748206 identifies DFFN - DIFFUSION PHARMACEUTICALS IN - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of DIFFUSION PHARMACEUTICALS IN - COM NEW (DFFN) as of Q2 2018

As of 30 Jun 2018, DIFFUSION PHARMACEUTICALS IN - COM NEW (DFFN) was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,858,704 shares. The largest 10 holders included Swift Run Capital Management, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, WHITTIER TRUST CO OF NEVADA INC, Virtu Financial LLC, CITADEL ADVISORS LLC, NORTHERN TRUST CORP, TWO SIGMA SECURITIES, LLC, Signature Financial Management, Inc., and PNC Financial Services Group, Inc.. This page lists 13 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.